Get Cash Back and $0 Commissions
+ The Power of TradeStation
Globe Newswire 31-Oct-2024 11:53 AM
DETROIT, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today its Founder and CEO, Dr. Ann Marie Sastry, was featured as a guest speaker at the Lesher Foundation's Newsmakers: 24/25 Season on October 24, 2024, following Former U.S. Representative Liz Cheney, Former World #1 Tennis Player and Founder of Chris Evert Charities, Chris Evert, Host of CNN's Smerconish and Best-Selling Author, Michael Smerconish and other eminent thinkers and experts.
Dr. Sastry talked about the impact of AI, and said that "AI allows you to reimagine yourself, and your capabilities." Commenting on the impact of AI in healthcare, Dr. Sastry said, "Technology exists that passes the U.S. Medical License Exam. Why wouldn't I want my healthcare provider to use AI? In fact, it's super crazy not to…we looked at this market and said, there are 5.2 million RNs and about 3.9 million caregivers, so we [at Amesite] said, ‘let's go help them'... My firm belief is that collectively the impact will be profound…it will be considered unethical not to use AI [in healthcare]."
Key topics covered by Dr. Sastry included:
A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/28c8a11b-dead-4b1b-8175-66c08bad9469
About Amesite Inc.
Amesite Inc. (NASDAQ:AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, including its higher ed platform that offers professional learning. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic™, the company's mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.
Forward Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact:
MJ Clyburn
TraDigital IR
clyburn@tradigitalir.com
Sources: